Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain
Clinical trial NCT05177094 · COMPLETED
Trial details
- NCT number
- NCT05177094
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-26
- Primary completion
- 2022-10-13
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.